Coloplast Historical Income Statement
| 0QBO Stock | 886.80 11.35 1.30% |
Historical analysis of Coloplast income statement accounts such as Interest Income of 152 M, Interest Expense of 0.0 or Selling General Administrative of 6.1 B can show how well Coloplast AS performed in making a profits. Evaluating Coloplast income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Coloplast's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Coloplast AS latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Coloplast AS is a good buy for the upcoming year.
Coloplast |
About Coloplast Income Statement Analysis
Coloplast AS Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Coloplast shareholders. The income statement also shows Coloplast investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Coloplast Income Statement Chart
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Total Revenue
Total revenue comprises all receipts Coloplast AS generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Coloplast AS minus its cost of goods sold. It is profit before Coloplast operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Coloplast's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Coloplast AS current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coloplast AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Interest Income is likely to gain to about 152 M in 2024, whereas Tax Provision is likely to drop slightly above 1.4 B in 2024.
| 2019 | 2020 | 2023 | 2024 (projected) | Interest Income | 360M | 100M | 115M | 152.0M | Tax Provision | 1.3B | 1.4B | 1.6B | 1.4B |
Coloplast income statement Correlations
Click cells to compare fundamentals
Coloplast Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Coloplast income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 1.2B | 1.2B | 1.3B | 1.4B | 1.6B | 1.4B | |
| Interest Income | 76M | 113M | 360M | 100M | 115M | 152.0M | |
| Selling General Administrative | 5.2B | 5.8B | 5.8B | 6.0B | 6.9B | 6.1B | |
| Total Revenue | 16.4B | 17.9B | 18.5B | 19.4B | 22.3B | 19.3B | |
| Gross Profit | 11.1B | 12.2B | 12.6B | 13.3B | 15.3B | 13.1B | |
| Operating Income | 5.1B | 5.2B | 5.9B | 6.2B | 7.1B | 6.0B | |
| Cost Of Revenue | 5.4B | 5.8B | 5.9B | 6.1B | 7.0B | 6.2B | |
| Income Before Tax | 5.0B | 5.0B | 5.5B | 6.2B | 7.2B | 5.9B | |
| Net Income Applicable To Common Shares | 3.9B | 4.2B | 4.8B | 4.7B | 5.4B | 4.6B | |
| Net Income | 3.8B | 3.9B | 4.2B | 4.8B | 5.5B | 4.5B | |
| Other Operating Expenses | 42M | 29M | 48M | 56M | 64.4M | 47.1M | |
| Ebit | 5.6B | 5.8B | 6.4B | 6.9B | 8.0B | 6.6B | |
| Income Tax Expense | 1.2B | 1.3B | 1.4B | 1.4B | 1.6B | 1.4B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Coloplast Stock Analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.